Older adults still worried, coping with COVID-19 Delta, poll shows

Published October 11, 2021 in RINewsToday

With the COVID-19 Delta variant numbers having surged across the nation, Joe (70) and Joyce (66), residing across the Rhode Island border in Seekonk, Massachusetts, continue to keep their distance from others, only seeing vaccinated friends and spending time with their daughter and her husband and grandchildren. During the first year of the pandemic, my friends pre-ordered their groceries and picked up the filled bags outside the store, where an employee quickly put the bags in their trunk. Now, this includes a quick 15-minute trip into the store, if necessary. They continue to not eat their meals in restaurants but will pick up their order curbside or eat outside.

Like my longtime friends, many older adults age 50 and over still remained concerned about this virus and continue to isolate themselves from others (especially those unvaccinated) and practice social distancing and wear their masks.

Still Feeling Socially Isolated

According to a newly released survey on Sept. 29, 2021, by the Associated Press-NORC Center for Public Affairs Research and funded by The SCAN Foundation, while a majority of adults age 50 or older see their quality of life, mental health, and satisfaction with social activities and relationships positively, they rarely, or never, feel socially isolated. But still, 18 months into the pandemic,1 in 3 still feel socially isolated at least sometimes. And 1 in 4 feels that their social life and relationships have gotten worse over the past year.

The poll survey includes 1,015 interviews with a nationally representative sample of adults age 50 and older living in America. Interviews were conducted between Aug. 20 and 23, 2021, via internet and phone, in English.

The research findings indicate that those older adults most worried about themselves or a loved one being infected by COVID-19 are most likely to practice social distancing, by avoiding travel, staying away from large groups of people, and wearing a mask. They are the ones most often experiencing feelings of social isolation. The researchers say that these people rate their quality of life, mental and emotional health, and social activities and relationships as worse than those less concerned about the virus.

The study’s findings indicate that being vaccinated does not provide the older persons with relief. Those who are vaccinated are more worried about infection from the virus, are more likely to practice social distancing, and are more likely to describe their mental health as worse than last year compared to those who are not vaccinated.

Touching Others Thru Video Chat and Social Media

To cope with isolation, older adults are using video chat and social media more often since the beginning of the pandemic as the frequency of activities like visiting with friends and family in person, doing volunteer work, attending religious services, and talking with neighbors have declined, the study’s findings indicate. And despite struggles with mental health and isolation, more report that their use of mental health services has declined (34%) than increased (6%).

In addition to the increasing use of technology to socialize, more older adults are using video chat, email, and other technology to receive health care remotely, say the researchers, noting that 63% have used telehealth at some point during the pandemic, up from 56% who had used it as of March 2021. Fifty-1% users expect to continue using it once the pandemic is over, too.

Still, adults age 50 and older are more optimistic than pessimistic that they will be able to fully return to their pre-pandemic activities in the next year, though 17% have already done so.

The results of The Associated Press-NORC Center for Public Affairs Research can be found in “Long-Term Care in America: Coronavirus Worries and Social Isolation among Older Adults,” released on Sept. 2021.

A Call for House Dems to Bring Back House Aging Committee

Published in RINewsToday on August 16, 2021

Just days ago, Congressman David Cicilline, along with fellow lawmakers, Jan Schakowsky (D-IL), Doris Matsui (D-CA), who serve as co-chairs of the House Democratic Caucus Task Force  on Aging and Families, introduced H. Res. 583 to amend the rules of the House to establish a House Permanent Select Committee on Aging. This is the Rhode Island lawmaker’s fourth attempt, and it might well succeed with two co-chairs of the House Caucus Task Force on Aging and Families cosponsoring the resolution.

Getting Schakowsky and Matsui on board is “very significant,” says Cicilline.  He also has the support of the prestigious Washington, D.C.-based Leadership Council on Aging Organizations (LCAO), representing 69 national aging groups.

The original House Permanent Select Committee on Aging, which was active between 1974 and 1992, conducted investigations, hearings and issues reports to inform Congress on issues related to aging, putting a legislative spotlight on the challenges and issues facing the growing aging population in America. 

H. Res. 583 would reestablish the House Aging Committee without having legislative jurisdiction, this being no different than when the permanent committee previously existed. It would be authorized to conduct a continuing comprehensive study and review of aging issues, such as income maintenance, poverty, housing, health (including medical research), welfare, employment, education, recreation, and long-term care. These efforts impacted legislation taken up by standing committees. It has been referred to the House Rules Committee for consideration.

It’s relatively simple to create an ad hoc (temporary) select committee, says the Congressional Research Service. All it takes is a simple resolution that contains language establishing the committee—giving a purpose, defining membership, and detailing other issues that need to be address.  Salaries and expenses of standing committees, special and select, are authorized through the Legislative Branch Appropriations bill.

An Urgent Time Requires Passage of H. Res. 583  

“America’s seniors have spent a lifetime working hard and moving our country forward and they deserve the best in their retirement,” says Cicilline. “The pandemic has disproportionately impacted seniors and now with growing concerns about inflation, seniors on fixed incomes will bear the burden of the rising cost of prescription drugs, food, housing, and other essentials,” he says, noting there has never been a more urgent time for Congress to reauthorize the House Permanent Select Committee on Aging than right now. 

“The pandemic magnified gaps in U.S. policy that routinely forget about Older Americans and the need to nurture a culture that respects them. From the lack of a universal long-term care policy to barriers to vaccine access earlier in the pandemic, these are issues that need to be examined so that Congress can put forward strong solutions to support our aging population and the communities they live in,” says Schakowsky. 

“Older Americans today face many difficulties—including achieving retirement security and affording the rising costs in health care and prescription drugs—which have only been worsened by the COVID-19 pandemic,” said Matsui, stressing by creating a House Aging Committee Congress can continue to strengthen and support policies that are important to seniors throughout the country. 

Supporters Call on House Resolution’s Passage 

As the Leadership Council of Aging Organizations (LCAO), the preeminent national organization representing and focused on the well-being of older adults, noted in its letter of support for reestablished the House Permanent Select Committee on Aging, “now is the opportune time to reestablish the HPSCoA. Every day, 12,000 Americans turn 60. By 2030, nearly 75 million people in the U.S.—or 20% of the country—will be age 65 or older. As America grows older, the need for support and services provided under programs like Social Security, SSI, Medicare, Medicaid and the Older Americans Act also increases.”

“We strongly support Cicilline’s legislation to re-establish the House Permanent Select Committee on Aging. This committee did crucial work on behalf of American seniors between 1974 and 1992, including investigating nursing home abuse, promoting breast cancer screening for older women, improving elderly housing, and bringing attention to elder abuse, among other issues,” says Max Richtman, president and CEO, National Committee to Preserve Social Security and Medicare, warning that “we should not wait another day to re-establish a committee dedicated to protecting America’s seniors.” 

“Cicilline is 100% right that it is time to re-establish this vital committee, with ten thousand Americans turning 65 every day, amid a pandemic that has taken a disproportionate toll on seniors.  Today, there are a new set of issues that demand the attention of a dedicated House committee — prescription drug pricing, long-term care, soaring medical costs and the future of Social Security and Medicare,” adds Richtman.

Bob Blancato who had the longest tenure of any staff on the Committee said: “First I commend Cicilline for introducing the legislation.  The timing was especially good as the release yesterday of the 2020 Census data shows a continued sharp increase in the number of older Americans in our nation.” 

“While I support this legislation it does face considerable odds to gain passage,” warns Blancato, noting that two things could change that.  “The resolution must have backing from House Leadership especially from Speaker Pelosi and it must become bipartisan as the original Committee was.  In the end it is about how do advocates make this into a political issue.  This is an opportunity for the Leadership Council of Aging Organizations to show if it has clout,” he says.

Adds, CEO Sandy Markwood, of National Association of Area Agencies on Aging: “We are a rapidly aging nation: one in five Americans will be age 65 or older within this decade. This historic demographic shift requires policymakers and the public to factor in aging and how we can age well at home and in the community into every policy conversation. For this, the House of Representatives should have a special aging committee as the Senate does: to spotlight not only older Americans, but also the impact of this massive shift on all generations, our communities and society at large. COVID-19 shone a bright spotlight on what we need to do to help older adults age well at home, but local aging leaders like n4a’s members need the House’s leadership to give aging policy the focused attention it deserves…and our demographics demand.”

According to Robert S. Weiner, a close friend and confident of House Aging Committee Chair Claude Pepper (D-Florida) who served as his committee Chief of Staff, the Special Committee was and can  again be the protector of seniors.  “Among its most significant actions — all bipartisan– were advocating and causing enactment of  the law, passed 359-2 in the House and 89-10 in the Senate, barring age based “mandatory retirement and protecting people over 40 from age discrimination,” he remembers.

“The courts are now fudging with that clear intent, and the House Aging Committee would be a visible and influential protector. Transparency by nursing homes and congregate housing settings– as mandated by laws pressed by Pepper decades ago but now ignored —  would be another benefit,” states Weiner. “In housing, health care, nutrition, crime victimization, transportation, accessibility, and social services –in the whole array of actions stopping ageism by local, state, and federal agencies and the courts, including the Supreme Court — the House Aging Committee would again be an invaluable champion for seniors,” he adds. 

“During the 117th Congress, passing H Res. 583 is also necessary to protect against under-the-radar political invasions of Social Security’s surplus — a fund paid by seniors in the program– and attempts to use the money to pay for other programs including tax cuts for the wealthy,” warns Weiner.

As a long-time Washington insider, Weiner says the best way to pass H Res 583 to reestablish the House Aging Committee is for the chief congressional advocate, Cicilline, to talk directly with the top three House leaders, Speaker Nancy Pelosi (D-CA), Majority Leader Steny Hoyer (D-MD and Whip James E. Clyburn (D-SC) and makes the case on the merits and bill’s support while asking for quick endorsement. “Looking back, “that’s how Pepper always did it – he’d pull people to a place on the floor and talk with them there, or on the phone. 

Weiner recalled how Pepper, the fierce aging advocate from Florida, called Rosalyn Carter to ask her husband, President Jimmy Carter for a meeting to discuss the mandatory retirement Carter who ultimately endorsed the bill.  It passed the House 359-2 and the Senate 89-10, being considered by Congress. Ultimately, “the full House Aging Committee (40 members) met with and there was a glorious White House signing ceremony,” he says.

A Call for House Leadership Support 

Cicilline goes into the 117th Congress with the support of long-time Congressional senior advocates, Schakowsky and Matsui and the backing of a prestigious coalition aging organizations to bring back the House Aging Committee.  It will happen this Congress if House Speaker Pelosi along with Majority Leader Hoyer and Whip Clyburn can bring the moderates and progressives of the Democratic House Caucus together to support H. Res. 583.  

Politically it’s the smart thing to do.  It’s a winning policy issue for America’s seniors and this group has traditionally been the highest turnout age group in elections.  But, more important, it’s the right thing to do especially at a time when seniors have been a disproportionately impacted by the continuing COVID-19 pandemic.    

I say pass H. Res. 583. 

Using Savings from Drug Pricing Reform to Expand Medicare

Published in RINewsToday on June 7, 2021

Ahead of President Biden’s first address to a joint session of Congress on April 28 and as the Democratic administration considers policies to slash rising drug costs, the U.S. Government Accountability Office (GAO) released a 65-page report finding that the U.S. pays more than two to four times higher prices for a selected sample of 20 single source, brand name drugs than Australia, Canada and France. The latest GAO report, commissioned by Sen. Bernie Sanders (I-Vt.), found that Americans, suffering from blood clots, bronchitis, emphysema and Hepatitis C, were paying more for life-saving treatments than patients in these industrialized countries. 

“This important GAO study confirms what we all already know: the pharmaceutical industry is ripping off the American people,” said Sen. Sanders in a statement announcing the March 29th release of the GAO report, “Prescription Drugs: US Prices for Selected Brand Drugs Were Higher on Average Than Prices in Australia, Canada and France.”

“The time is long overdue for the United States to do what every major country on earth does: negotiate with the pharmaceutical companies to lower the outrageous price of prescription drugs. I would urge the president to put this proposal in the American Families Plan and use the savings to expand and improve Medicare for older Americans. We can no longer tolerate the American people paying, by far, the highest prices in the world for prescription drugs,” says the Vermont Senator who chairs the Senate’s Budget Committee.

U.S. Paying Outrageous Drug Prices

The GAO study found that in 2020, the U.S. paid 4.36 times more than France, 4.25 times more than Australia and 2.82 times more than Canada for the selected drugs, which represent a sample of the drugs with the highest Medicare Part D expenditures and use. The researchers noted that the publicly available data for the comparison countries were gross prices that did not reflect potential discounts. As a result, the actual differences between U.S. prices and those of the other countries were likely much larger than GAO estimates.

According to the GAO report, while France and Australia operate universal, publicly funded health systems that include prescription drug coverage, both Canada and the U.S. have a significant number of people who do not have prescription drug coverage. But even when comparing the full cash retail prices of selected drugs, the prices quoted to individuals without prescription drug coverage, GAO found that prices were two to eight times higher in the U.S. than the same drugs from pharmacies in Canada. 

For instance, GAO found that the cash price of Epclusa (28 tablets), which treats Hepatitis C, or an infection that attacks the liver, is $36,743 in the U.S. but $17,023.63 in Canada. The cash price of Harvoni (28 tablets), which also treats Hepatitis C, is $46,570.33 in the U.S. but $19,084.54 in Canada. In another example, GAO cited that the cash price of Incruse Ellipta Inhalation Powder (30 inhalations), which treats chronic obstructive pulmonary disease (COPD), or a group of lung diseases which block airflow and make it difficult to breath, is $411.33 in the U.S. but $53.31 in Canada.

Because France and Australia have universal health systems that cover prescription drugs, Australians would pay up to a $28.09 copay for a month supply of these medicines, while patients in France would pay anywhere from $0 to $34.03 for the drugs. The maximum copay that high income seniors with prescription drug coverage in Ontario, Canada would pay for the drugs is $4.67.

Robbing Peter to Pay Paul

On April 23, 48, organizations, led by Indivisible, Social Security Works and Public Citizen, called on Biden to include bold drug pricing reforms in American Families Plan to expand Medicare, and the result of a new polls supports this legislative action. 

Drug pricing reform will produce upward of $450 billion in savings over 10 years, note the organizations, urging Biden to use these savings to reinvest in Medicare. The call for adding dental, vision and hearing benefits to Medicare, lowering the Medicare eligibility age to 50 and creating an out-of-pocket cap for medical expenses.

Alongside the letter, the organizations released the findings of a new poll from Data for Progress, widespread public support across party lines for expanding and improving Medicare. The poll’s findings noted that 86% of Americans, including 82% of Republicans, support adding dental, hearing and vision benefits to Medicare. It also found that three-quarters of Democrats, a majority of independents, and nearly half of Republicans support lowering the Medicare eligibility age to 55. 

“Allowing Medicare to negotiate drug prices down saves money for the federal government, which is the largest buyer of prescription drugs in the world,” said Alex Lawson, Executive Director of Social Security Works. “We must pump those savings back into Medicare to expand eligibility and add benefits that equalize Medicare with private insurance,” he says.

“Lowering the Medicare eligibility age to 50, capping out-of-pocket costs, and expanding benefits to include dental, hearing, and vision would improve access to care for millions of Americans. Far too many Americans have lost their insurance or put off needed care due to the COVID-19 crisis,” said Eagan Kemp, Health Care Policy Advocate for Public Citizen. “The Biden Administration and Congress have a chance to deliver important progress at a crucial time,” he says.

Adds Mary Small, Legislative Director for Indivisible, “With the consequences of the COVID-19 pandemic still being felt in our communities, now is a crucial moment to expand public health care coverage and deliver savings on prescription drug prices to the American people. Lowering the Medicare eligibility age to 50 will be an essential step toward reducing the racial health inequities by increasing coverage to communities of color and low-income folks.”  She adds, “Allowing Medicare to negotiate prescription drug prices and then reinvesting those savings back into the program to expand services further strengthens our path toward universal coverage for all.” 

Last Thoughts

Garnering applause, Biden put high drug costs on his Administration’s radar screen at his recent address before Congress. “Let’s give Medicare the power to save hundreds of billions of dollars by negotiating lower drug prescription prices. It won’t just help people on Medicare. It will lower prescription drug costs for everyone,” said the 46th President of the United States. “We’ve talked about it long enough. Democrats and Republicans, let’s get it done this year,” he said.

But actions speak louder than words, say Washington Insiders.  They note that Biden’s American Families Plan, did not include any proposal to slash pharmaceutical costs or lower the Medicare eligibility age. Is it possible for Biden to lower the drug prices in the United States, making the prices more comparable to other industrialized countries and to even expand Medicare, in the face of fierce opposition from Republicans, moderate Senate Democrats and pharmaceutical companies?  

According to the latest KFF Health Tracking Poll released June 3, 2021, the findings indicate that “nearly nine in 10 (88%) favor allowing the federal government to negotiate for lower prices on medications, including three-fourths (77%) of Republicans, nine in 10 independents (89%) and 96% of Democrats.” However, support dwindles “when the public hears argument made by pharmaceutical companies that it could lead to less research and development for new drugs, or that access to newer prescriptions could be limited,” say the researchers.

Will political pressure sway a divided Congress before the upcoming midterm elections to hammer out a bipartisan solution to put the brakes to the nation’s skyrocketing drug costs and to provide more American’s affordable health care through an expanded Medicare program. Its wait and see.